Pharma

Emcure Pharmaceuticals Ltd

EMCURE · NSE · INE168P01015
₹1,833.5+2.99%consolidatedstandalone
Tuesday, 27 Oct 202610:01 am
Sentiment68 · Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹34,783 Cr
P/E34.4
P/B7.0
EPS₹53.35
Div Yield0.2%
ROE20.0%
ROCE23.0%
ROE20.0%
1Y Return+23.67%
Avg. Volume0.1M

Price Chart

2,0101,8371,6641,4911,31827.4L54.7LOct 2025Nov 2025Dec 2025Feb 2026Mar 2026Apr 2026May 2026Jul 2026Sept 2026

52-Week Range

₹1,306.5₹1,833.5₹2,100.7
52W Low52W High

About

Emcure Pharmaceuticals Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹34,783 Cr
Current Price₹1,833.5
52W High / Low₹2,100.7 / ₹1,306.5
Stock P/E34.4
Price to Book7.0
EPS (TTM)₹53.35
Dividend Yield0.2%
ROE20.0%
1Y Return+23.67%
Day Change+2.99%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19
Sales₹9,683 Cr₹9,204 Cr₹7,896 Cr
Expenses₹7,703 Cr₹7,458 Cr₹6,427 Cr
Operating Profit₹1,980 Cr₹1,746 Cr₹1,469 Cr
OPM %20.0%19.0%19.0%
Other Income₹-17 Cr₹100 Cr₹62 Cr
Depreciation₹425 Cr₹415 Cr₹384 Cr
Interest₹148 Cr₹144 Cr₹176 Cr
Profit Before Tax₹1,390 Cr₹1,287 Cr₹971 Cr
Tax₹371 Cr₹346 Cr₹264 Cr
Net Profit₹1,019 Cr₹941 Cr₹707 Cr
EPS (₹)53.348.836.0
Dividend Payout %—7%8%
Financial history locked

Register free to see 6 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹2,580 Cr₹2,470 Cr₹2,363 Cr₹2,270 Cr
Expenses₹2,048 Cr₹1,990 Cr₹1,871 Cr₹1,794 Cr
Operating Profit₹532 Cr₹480 Cr₹493 Cr₹475 Cr
OPM %21.0%19.0%21.0%21.0%
Depreciation₹110 Cr₹106 Cr₹105 Cr₹105 Cr
Interest₹32 Cr₹46 Cr₹38 Cr₹33 Cr
Net Profit₹292 Cr₹244 Cr₹231 Cr₹251 Cr
EPS (₹)15.512.812.212.8
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19
Liabilities
Equity Capital₹190 Cr₹189 Cr₹181 Cr
Reserves₹4,760 Cr₹4,257 Cr₹2,771 Cr
Borrowings₹1,521 Cr₹1,023 Cr₹2,335 Cr
Other Liabilities₹3,043 Cr₹2,653 Cr₹2,422 Cr
Total Liabilities₹9,514 Cr₹8,122 Cr₹7,709 Cr
Assets
Fixed Assets₹3,319 Cr₹3,197 Cr₹3,125 Cr
Investments₹20 Cr₹95 Cr₹318 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹5,903 Cr₹4,652 Cr₹4,108 Cr
Total Assets₹9,514 Cr₹8,122 Cr₹7,709 Cr
Balance sheet history locked

Register free to see 6 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹944 Cr₹-1,175 Cr₹343 Cr₹112 Cr
FY25₹852 Cr₹-96 Cr₹-814 Cr₹-58 Cr
FY24₹1,097 Cr₹-715 Cr₹-164 Cr₹219 Cr
FY23
FY22
FY21
FY20
FY19
Cash flow history locked

Register free to see 6 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd——+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-21Shareholder Meeting / Postal Ballot-Outcome of AGMBSE Filing2026-08-08Emcure Pharmaceuticals Ltd (BOM:544210) (Q1 2027) Earnings Call Highlights: Revenue Surges 22. ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.